Brooklyn Immunotherapeutics LLC
Records under this name other than the patents Brooklyn Immunotherapeutics LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Back to Brooklyn Immunotherapeutics LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,931,378 | Method of Immunotherapy for Treatment of Human Papillomavirus Infection Lapsed on the fee record Ended Apr 3, 2026 · Medium confidence | Lapsed on the fee record | Ended Apr 3, 2026 | Medium confidence |
| US 8,591,956 | Method of Increasing Immunological Effect Lapsed on the fee record Ended Nov 26, 2025 · High confidence | Lapsed on the fee record | Ended Nov 26, 2025 | High confidence |
| US 8,470,562 | IRX-2 Modified Manufacturing Process Lapsed on the fee record Ended Jun 25, 2025 · High confidence | Lapsed on the fee record | Ended Jun 25, 2025 | High confidence |
| US 9,566,331 | Vaccine Immunotherapy Lapsed on the fee record Ended Feb 14, 2025 · High confidence | Lapsed on the fee record | Ended Feb 14, 2025 | High confidence |
| US 7,731,945 | Immunotherapy for Reversing Immune Suppression Term ended Ended no later than Feb 6, 2025 · Medium confidence | Term ended | Ended no later than Feb 6, 2025 | Medium confidence |
| US 9,539,320 | Vaccine Immunotherapy Lapsed on the fee record Ended Jan 10, 2025 · High confidence | Lapsed on the fee record | Ended Jan 10, 2025 | High confidence |
| US 9,492,517 | Vaccine Immunotherapy Term ended Term ended Feb 25, 2024 · High confidence | Term ended | Term ended Feb 25, 2024 | High confidence |
| US 9,789,172 | Vaccine Immunotherapy for Treating Lymphoma in Immune Suppressed Patients Term ended Term ended Aug 17, 2023 · High confidence | Term ended | Term ended Aug 17, 2023 | High confidence |
| US 9,789,173 | Vaccine Immunotherapy for Treating Cervical Cancer in Immune Suppressed Patients Term ended Term ended Aug 17, 2023 · High confidence | Term ended | Term ended Aug 17, 2023 | High confidence |
| US 9,492,519 | Vaccine Immunotherapy Term ended Term ended Jun 30, 2023 · High confidence | Term ended | Term ended Jun 30, 2023 | High confidence |